Article
Extremely aggressive course in a poorly differentiated thyroid carcinoma presenting a double mutation of the TERT promoter.
The American journal of the medical sciences - 1 Jun 2023
Zantut-Wittmann D E, Laus A C, Moreno D A, Barreto I S, Moma C A, Maia F F R, Etchebehere E C S C, Assumpção L V M, Reis R M
Abstract excerpt
BRAF and TERT oncogenes hotspot mutations are associated with a more aggressive outcome in thyroid carcinomas (TC). TERT promoter (pTERT) mutations (C228T and C250T) are related to cancer growth and reduced overall- and disease-free survivals in TC. We report a patient followed up for 8 years with a poorly differentiated thyroid carcinoma (PDTC) presenting an extremely aggressive course, who developed a large...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
